Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Experimental Lung Research is Scopus-indexed (Q3, CiteScore 3.1), WoS SCIE, DOAJ. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 0190-2148Verify ISSN ↗1521-0499Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 87 / 165 | 47th | Q3 |
| Clinical Biochemistry | 82 / 124 | 34th | Q3 |
| Molecular Biology | 316 / 414 | 23rd | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1980–present, best quartile Q3, CiteScore 3.1.
Experimental Lung Research is Q3 in Pulmonary and Respiratory Medicine (rank 87 of 165), Q3 in Clinical Biochemistry (rank 82 of 124) and Q4 in Molecular Biology (rank 316 of 414), by CiteScore 2025.
Experimental Lung Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.1, which places it in quartile Q3 at the 47th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.553, quartile Q2, with an H-index of 60.
Experimental Lung Research is published by Taylor and Francis Ltd. Its print ISSN is 0190-2148 and its online ISSN is 1521-0499.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Experimental Lung Research has an h-index of 79 and a 2-year mean of 2.14 citations per paper (OpenAlex). Its Scopus CiteScore is 3.1, quartile Q3. On 2-year citations it ranks #55 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Experimental Lung Research published 16 papers in 2025; its busiest recent year was 2020 with 47. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2021–2026), authors are most often from China (60.2%), United States (5.6%) and Türkiye (4.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.